News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Mimetogen Pharmaceuticals Raises Series A; Partners With McGill University
March 24, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
3/24/2006 – Mimetogen Pharmaceuticals Inc., a small molecule drug development company, said it has completed an undisclosed amount of Series A equity financing.
Twitter
LinkedIn
Facebook
Email
Print
Startups
MORE ON THIS TOPIC
Inflammatory bowel disease
Roche Makes Preclinical IBD Play in $420M+ OMass Pact
September 2, 2025
·
2 min read
·
Tristan Manalac
Layoff Tracker
Exelixis Cuts Go Beyond Pennsylvania, Include 71 at California HQ
August 29, 2025
·
194 min read
·
BioSpace Editorial Staff
Layoffs
Exelixis Lays Off 130 as Pennsylvania Site Closes Down
August 28, 2025
·
2 min read
·
Tristan Manalac
Obesity
Novo Seeks RNA Approach to Obesity, Diabetes With $550M Replicate Deal
August 28, 2025
·
1 min read
·
Tristan Manalac
